Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Free Cash Flow: -59.62M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -59.62M |
| June 30, 2024 | -65.93M |
| March 31, 2024 | -54.28M |
| December 31, 2023 | -38.94M |
| September 30, 2023 | -29.22M |
| June 30, 2023 | -12.60M |
| March 31, 2023 | -15.21M |
| December 31, 2022 | -18.95M |
| September 30, 2022 | -22.87M |
| June 30, 2022 | -35.25M |
| March 31, 2022 | -25.71M |
| December 31, 2021 | -28.46M |
| September 30, 2021 | -26.17M |
| June 30, 2021 | -23.26M |
| Date | Value |
|---|---|
| March 31, 2021 | -34.17M |
| December 31, 2020 | -31.68M |
| September 30, 2020 | -33.25M |
| June 30, 2020 | -33.44M |
| March 31, 2020 | -29.78M |
| December 31, 2019 | -28.09M |
| September 30, 2019 | -27.43M |
| June 30, 2019 | -24.67M |
| March 31, 2019 | -23.39M |
| December 31, 2018 | -18.65M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -8.756M |
| March 31, 2018 | -6.228M |
| December 31, 2017 | -4.583M |
Free Cash Flow Range, Past 5 Years
-65.93M
Minimum
Jun 2024
-12.60M
Maximum
Jun 2023
-32.34M
Average
-29.50M
Median
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| Elite Pharmaceuticals Inc | 1.685M |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | -46.04M |
| Terns Pharmaceuticals Inc | -74.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.558M |
| Cash from Investing (Quarterly) | -0.016M |
| Cash from Financing (Quarterly) | -0.397M |
| Free Cash Flow Per Share (Quarterly) | -0.1832 |
| Free Cash Flow to Equity (Quarterly) | -9.128M |
| Free Cash Flow Yield | -128.9% |